Finance

Lists
IOF:LON
Iofina plc
GBX 55.32
+0.58%
(+0.32) 1D
Oct 13, 9:33:31 AM GMT+1  ·   GBX
All symbols
SymbolPriceChange% Change
Generating top insights for IOF...
Open
GBX 55.32
High
GBX 56.00
Low
GBX 54.00
Mkt. cap
106.08M
Avg. vol.
336.16K
Volume
11.13K
P/E ratio
15.86
52-wk high
GBX 60.12
52-wk low
GBX 20.00
EPS
GBX 0.03
Shares outstanding
191.86M
No. of employees
126
Open
GBX 55.32
High
GBX 56.00
Low
GBX 54.00
Mkt. cap
106.08M
Avg. vol.
336.16K
Volume
11.13K
P/E ratio
15.86
52-wk high
GBX 60.12
52-wk low
GBX 20.00
EPS
GBX 0.03
Shares outstanding
191.86M
No. of employees
126
News stories
From web sources and news partners
Profile
Iofina plc is a US based vertically integrated company that specializes in the exploration and production of iodine and the manufacturing of specialty chemical derivatives. It markets around the globe via its business lines, Iofina Resources and Iofina Chemical. Iofina Resources is the group's iodine production business, which isolates iodine using its proprietary WET IOsorb technologies. It isolates iodine recovered from brine produced from oil and gas operations that would otherwise be wasted. It is the second-largest producer of iodine in North America, which currently imports the vast majority of its iodine. Iodine has numerous applications in human health, biocides, the manufacture of acetic, and many other areas. IR's iodine is either sold directly to global customers or converted to iodine-based compounds at its sister company, Iofina Chemical. Iofina Chemical is the group's halogen-based specialty chemical producer. IC has invested heavily in researching and developing new iodo-, chloro-, and fluoro-based specialty compounds and provides the global market with quality iodine products. Wikipedia
About Iofina plc
CEO-
Employees126
Founded2005
Headquarters-
SectorSpeciality chemicals
Websiteiofina.com
Previous reports
Loading Previous Earnings...
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
18.67M
18.67M
15.67M
15.67M
Cost of goods sold
12.82M
12.82M
10.56M
10.56M
Cost of revenue
12.82M
12.82M
10.56M
10.56M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1.59M
1.59M
1.78M
1.78M
Operating expense
2.40M
2.40M
2.65M
2.65M
Total operating expenses
15.21M
15.21M
13.22M
13.22M
Operating income
3.46M
3.46M
2.45M
2.45M
Other non operating income
-
-
-
-
EBT including unusual items
3.53M
3.53M
2.45M
2.45M
EBT excluding unusual items
3.40M
3.40M
2.45M
2.45M
Income tax expense
851.00K
851.00K
700.50K
700.50K
Effective tax rate
24.10%
24.10%
28.62%
28.62%
Other operating expenses
-
-
-
-
Net income
2.68M
2.68M
1.75M
1.75M
Net profit margin
14.35%
14.35%
11.15%
11.15%
Earnings per share
-
-
-
-
Interest and investment income
52.50K
52.50K
84.50K
84.50K
Interest expense
-116.00K
-116.00K
-90.00K
-90.00K
Net interest expenses
-63.50K
-63.50K
-5.50K
-5.50K
Depreciation and amortization charges
808.50K
808.50K
866.50K
866.50K
EBITDA
4.22M
4.22M
3.32M
3.32M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google apps